LMR Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-39,300
Closed -$3.78M 1711
2025
Q4
$3.78M Sell
39,300
-15,500
-28% -$1.51M 0.01% 646
2025
Q3
$5.22M Sell
54,800
-1,400
-2% -$129K 0.02% 505
2025
Q2
$4.9M Sell
56,200
-38,600
-41% -$3.27M 0.04% 452
2025
Q1
$8.52M Buy
94,800
+50,700
+115% +$4.54M 0.08% 282
2024
Q4
$3.52M Sell
44,100
-47,500
-52% -$4.11M 0.03% 471
2024
Q3
$8.25M Hold
91,600
0.07% 248
2024
Q2
$7.21M Hold
91,600
0.06% 259
2024
Q1
$7.98M Hold
91,600
0.08% 226
2023
Q4
$7.55M Buy
+91,600
New +$6.98M 0.09% 232

Other funds holding MDT

LMR Partners's MDT Position: Q1 2026 in Review

LMR Partners increased its Medtronic (MDT) stake by 572% in Q1 2026, buying an estimated $1.58M and bringing the position to 19,373 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #882.

LMR Partners first reported a position in MDT in Q1 2015 and has held it in 23 quarters since. The position peaked at $9.08M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • LMR Partners held 19,373 shares of Medtronic worth $1.68M as of Q1 2026.
  • LMR Partners bought 16,490 Medtronic shares in Q1 2026, an estimated $1.58M.
  • Medtronic made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #882 holding.
  • LMR Partners first reported a position in Medtronic in Q1 2015 and has held it in 23 quarters since.
  • LMR Partners's Medtronic position peaked at $9.08M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.